A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients

Cancer Investigation

Volumn 19, Issue 1, 2001, Pages 13-22

  Tyring, S ^a   Belanger, R ^a   Bezwoda, W ^a   Ljungman, P ^a   Boon, R ^a   Saltzman, R L ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FAMCICLOVIR; 2 AMINOPURINE; ANTIVIRUS AGENT; DRUG DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HERPES; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; VARICELLA ZOSTER VIRUS; AGED; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; HERPES ZOSTER; MIDDLE AGED; MULTICENTER STUDY; PAIN; SKIN DISEASE;

2-AMINOPURINE; ACYCLOVIR; ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; HERPES ZOSTER; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; PAIN; SKIN DISEASES;

EID: 0034745159     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-100000070     Document Type: Article

References (21)

1. Chemoprophylaxis of viral infection in immunocompromised patients
2. Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: Randomized double-blind trial
3. Infection with varicella-zoster virus after marrow transplantation
4. A longitudinal study of varicella-zoster virus infections in renal transplant recipients
5. Clinically evident, nonterminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients
6. Cellular immunity and herpesvirus infections in cardiac-transplant patients
7. Acyclovir halts progression of herpes zoster in immunocompromised patients
8. Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine
9. A randomized trial of oral versus intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients
10. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients
11. Acyclovir: An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy
12. Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients
13. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation
14. Manifestations resembling thrombotic microangiopathy in patients with advanced Human Immunodeficiency Virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204)
15. Inhibition of varicella zoster virus by penciclovir in cell culture and mechanism of action
16. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type I (HSV-1), HSV-2 and varicella-zoster virus
17. Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg
18. Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial
19. Trials to assess equivalence: The importance of rigorous methods
20. Sample size requirements for evaluating a conservative therapy
21. Active control equivalence studies